1477-7525 < 1478-6354 < 1478-6362

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
000013 (2020)	Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis]	Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes
000104 (2019)	Ivan Foeldvari [Allemagne] ; Tamàs Constantin [Hongrie] ; Jelena Vojinovi [Serbie] ; Gerd Horneff [Allemagne] ; Vyacheslav Chasnyk [Russie] ; Joke Dehoorne [Belgique] ; Violeta Panaviene [Lituanie] ; Gordana Suši [Serbie] ; Valda Stanevicha [Lettonie] ; Katarzyna Kobusinska [Pologne] ; Zbigniew Zuber [Pologne] ; Bogna Dobrzyniecka [Pologne] ; Irina Nikishina [Russie] ; Brigitte Bader-Meunier [France] ; Luciana Breda [Italie] ; Pavla Doležalová [République tchèque] ; Chantal Job-Deslandre [France] ; Ingrida Rumba-Rozenfelde [Lettonie] ; Nico Wulffraat [Pays-Bas] ; Ronald D. Pedersen [États-Unis] ; Jack F. Bukowski [États-Unis] ; Bonnie Vlahos [États-Unis] ; Alberto Martini [Italie] ; Nicolino Ruperto [Italie]	Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial
000124 (2019)	François Vercruysse [France] ; Thomas Barnetche [France] ; Estibaliz Lazaro [France] ; Emilie Shipley [France] ; François Lifermann [France] ; Alexandre Balageas [France] ; Xavier Delbrel [France] ; Bruno Fautrel [France] ; Christophe Richez [France] ; Thierry Schaeverbeke [France] ; Marie-Elise Truchetet [France]	Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
000125 (2019)	Amayelle Rey [France] ; Benjamin Batteux [France] ; Solène M. Laville [France] ; Justine Marienne [France] ; Kamel Masmoudi [France] ; Valérie Gras-Champel [France] ; Sophie Liabeuf [France]	Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
000145 (2018)	Anaïs Huwart [France] ; Florent Garrigues [France] ; Sandrine Jousse-Joulin [France] ; Thierry Marhadour [France] ; Dewi Guellec [France] ; Divi Cornec [France] ; Maelenn Gouillou [France] ; Alain Saraux [France] ; Valérie Devauchelle-Pensec [France]	Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab
000154 (2018)	Gonçalo Boleto [France] ; Christophe Guignabert [France] ; Sonia Pezet [France] ; Anne Cauvet [France] ; Jérémy Sadoine [France] ; Ly Tu [France] ; Carole Nicco [France] ; Camille Gobeaux [France] ; Frédéric Batteux [France] ; Yannick Allanore [France] ; Jérôme Avouac [France]	T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis
000155 (2018)	Sabine Adler [Suisse] ; Dörte Huscher [Allemagne] ; Elise Siegert [Allemagne] ; Yannick Allanore [France] ; Lászl Czirják [Hongrie] ; Francesco Delgaldo [Royaume-Uni] ; Christopher P. Denton [Royaume-Uni] ; Oliver Distler [Suisse] ; Marc Frerix [Allemagne] ; Marco Matucci-Cerinic [Italie] ; Ulf Mueller-Ladner [Allemagne] ; Ingo-Helmut Tarner [Allemagne] ; Gabriele Valentini [Italie] ; Ulrich A. Walker [Suisse] ; Peter M. Villiger [Suisse] ; Gabriela Riemekasten [Allemagne]	Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
000159 (2018)	Elodie Rivière [France] ; Jérémie Sellam [France] ; Juliette Pascaud [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France]	Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
000169 (2018)	Joost Swart [Pays-Bas] ; Gabriella Giancane [Italie] ; Gerd Horneff [Allemagne] ; Bo Magnusson [Suède] ; Michael Hofer [Suisse] ; Katerina Alexeeva [Russie] ; Violeta Panaviene [Lituanie] ; Brigitte Bader-Meunier [France] ; Jordi Anton [Espagne] ; Susan Nielsen [Danemark] ; Fabrizio De Benedetti [Italie] ; Sylvia Kamphuis [Pays-Bas] ; Valda Sta Vi A ; Maria Tracahana [Grèce] ; Laura Marinela Ailioaie [Roumanie] ; Elena Tsitsami [Grèce] ; Ariane Klein [Allemagne] ; Kirsten Minden [Allemagne] ; Ivan Foeldvari [Allemagne] ; Johannes Peter Haas [Allemagne] ; Jens Klotsche [Allemagne] ; Anna Carin Horne [Suède] ; Alessandro Consolaro [Italie] ; Francesca Bovis [Italie] ; Francesca Bagnasco [Italie] ; Angela Pistorio [Italie] ; Alberto Martini [Italie] ; Nico Wulffraat [Pays-Bas] ; Nicolino Ruperto [Italie]	Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries
000171 (2018)	Vibeke Strand [États-Unis] ; Laure Gossec [France] ; Clare W. J. Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Matthew Reaney [Royaume-Uni] ; Sophie Guillonneau [France] ; Toshio Kimura [États-Unis] ; Janet Van Adelsberg [États-Unis] ; Yong Lin [États-Unis] ; Erin K. Mangan [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Gerd R. Burmester [Allemagne]	Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
000213 (2018)	Rieke Alten [Allemagne] ; Harald Burkhardt [Allemagne] ; Eugen Feist [Allemagne] ; Klaus Krüger [Allemagne] ; Juergen Rech [Allemagne] ; Andrea Rubbert-Roth [Allemagne] ; Reinhard E. Voll [Allemagne] ; Yedid Elbez [France] ; Christiane Rauch [Allemagne]	Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting
000237 (2017)	Sarah Salomon [France] ; Caroline Guignant [France] ; Pierre Morel [France] ; Gauthier Flahaut [France] ; Clément Brault [France] ; Clément Gourguechon [France] ; Patrice Fardellone [France] ; Jean-Pierre Marolleau [France] ; Brigitte Gubler [France] ; Vincent Goëb [France]	Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
000252 (2017)	C. Derambure [France] ; G. Dzangue-Tchoupou [France] ; C. Berard [France] ; N. Vergne [France] ; M. Hiron [France] ; M. A. D Gostino [France] ; P. Musette [France] ; O. Vittecoq [France] ; T. Lequerré [France]	Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis
000313 (2016)	Anita Boyapati [États-Unis] ; Jérôme Msihid [France] ; Stefano Fiore [États-Unis] ; Janet Van Adelsberg [États-Unis] ; Neil M. H. Graham [États-Unis] ; Jennifer D. Hamilton [États-Unis]	Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY
000328 (2016)	Daniël Van Der Velden [Pays-Bas] ; H. Maxime Lagraauw [Pays-Bas] ; Anouk Wezel [Pays-Bas] ; Pierre Launay [France] ; Johan Kuiper [Pays-Bas] ; Tom W. J. Huizinga [Pays-Bas] ; René E. M. Toes [Pays-Bas] ; Ilze Bot [Pays-Bas] ; Jeroen N. Stoop [Pays-Bas]	Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile
000352 (2016)	Marie-Elise Truchetet [France] ; Nicolas Poursac [France] ; Thomas Barnetche [France] ; Emilie Shipley [France] ; Jacques-Eric Gottenberg [France] ; Bernard Bannwarth [France] ; Christophe Richez [France] ; Thierry Schaeverbeke [France]	Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
000370 (2015)	Michael E. Weinblatt [États-Unis] ; Roy Fleischmann [États-Unis] ; Ronald F. Van Vollenhoven [Suède] ; Paul Emery [Royaume-Uni] ; Tom Wj Huizinga [Pays-Bas] ; Maurizio Cutolo [Italie] ; Désirée Van Der Heijde [Pays-Bas] ; Benjamin Duncan [États-Unis] ; Owen Davies [Belgique] ; Kristel Luijtens [États-Unis] ; Maxime Dougados [France]	Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population
000387 (2015)	Rachel Audo [France] ; Claire Daien [France] ; Laura Papon [France] ; Cédric Lukas [France] ; Olivier Vittecoq [France] ; Michael Hahne [France, Pays-Bas] ; Bernard Combe [France] ; Jacques Morel [France]	Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort
000397 (2015)	Karine Louati [France] ; Francis Berenbaum [France]	Fatigue in chronic inflammation - a link to pain pathways
000415 (2015)	Josef S. Smolen ; Jürgen Wollenhaupt [Allemagne] ; Juan J. Gomez-Reino [Espagne] ; Walter Grassi [Italie] ; Corine Gaillez [France] ; Coralie Poncet [France] ; Manuela Le Bars [France] ; Rene Westhovens [Belgique]	Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)
000435 (2014)	Lucille Desallais [France] ; Jérôme Avouac [France] ; Maxime Fréchet [France] ; Muriel Elhai [France] ; Rojo Ratsimandresy [France] ; Matthieu Montes [France] ; Hadley Mouhsine [France] ; Hervé Do [France] ; Jean-François Zagury [France] ; Yannick Allanore [France]	Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/ISSN.i -k "1478-6354" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/ISSN.i  \
                -Sk "1478-6354" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1478-6354
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021